Back to Journals » Drug Design, Development and Therapy » Volume 13

Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report

Total article views   Abstract views HTML views PDF downloads Totals
3,046 Dovepress* 2,778 138+ 348 2,916
PubMed Central* 0 130 52 130
Totals 2,778 268 400 3,046
*Since 11 January 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar